START New Jersey — East Brunswick, New Jersey

Public research footprint of START New Jersey, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Most-studied conditions

mCRPC (Metastatic Castration-resistant Prostate Cancer) · Prostatic Neoplasms · Neoplasms of Prostate · Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including…

Recently updated registry entries

NCT07743541 — Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After… (Not Yet Recruiting)
NCT07719361 — A Study in Patients With Metastatic Castration-Resistant Prostate Cancer (Recruiting)
NCT07644559 — A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at START New Jersey?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.